<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02371538</url>
  </required_header>
  <id_info>
    <org_study_id>2014-3363</org_study_id>
    <nct_id>NCT02371538</nct_id>
  </id_info>
  <brief_title>Human Breastmilk in Young Children With Norovirus Infection of the Gut</brief_title>
  <official_title>A Pilot Study of Enteral Donor Human Milk in Young Children With Norovirus Infection of the Gut</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Children's Hospital Medical Center, Cincinnati</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Mothers' Milk Bank Northeast</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Children's Hospital Medical Center, Cincinnati</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Human Breast milk in young children with Norovirus Infection&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators hypothesize that children with clinically significant norovirus infection&#xD;
      of the gut who receive enteral human milk will more successfully clear the virus or&#xD;
      experience improved symptoms compared to children not receiving human milk.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Slow accrual.&#xD;
  </why_stopped>
  <start_date>October 2014</start_date>
  <completion_date type="Actual">July 2, 2016</completion_date>
  <primary_completion_date type="Actual">July 2, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Loose/Unformed/Liquid Stools or Abdominal Cramping</measure>
    <time_frame>Up to 12 weeks</time_frame>
    <description>Episodes or number of days of loose/unformed/liquid stools or abdominal cramping will be reported.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Norovirus</measure>
    <time_frame>Up to 12 weeks</time_frame>
    <description>Stool samples will be tested for the presence of norovirus.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">4</enrollment>
  <condition>Norovirus Infections</condition>
  <arm_group>
    <arm_group_label>Donor Breastmilk</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Donated human milk is subjected to pasteurization prior to use. Milk consumption is to be overseen by a Registered Dietician. Oral or enteral milk feeding will begin at 180 ml/day and will be advanced as quickly as tolerated to a goal of 360 ml/day for 6 weeks. If symptoms and stool tests for norovirus do not improve after 6 weeks, milk administration may continue for an additional 6 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Donor Breastmilk</intervention_name>
    <description>Donor breastmilk will be obtained from the Mother's Milk Bank of New England.</description>
    <arm_group_label>Donor Breastmilk</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Children with at least two stool samples taken at least 7 days apart that are positive&#xD;
             for norovirus&#xD;
&#xD;
          -  Child has an underlying disease or has received immunosuppressive medication or&#xD;
             chemotherapy such that clearance of norovirus is expected to be impaired.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  The presence of other pathogens causing diarrhea that have specific treatments does&#xD;
             not preclude enrollment. However, specific treatment should be offered in addition to&#xD;
             human milk.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Javier El-Bietar, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Hospital Medical Center, Cincinnati</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cincinnati Children's Hospital Medical Center</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45229</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>February 19, 2015</study_first_submitted>
  <study_first_submitted_qc>February 19, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 25, 2015</study_first_posted>
  <last_update_submitted>August 18, 2020</last_update_submitted>
  <last_update_submitted_qc>August 18, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>stem cell transplant</keyword>
  <keyword>human breastmilk</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Caliciviridae Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

